Galenica AG (GALE.SW) Stock Analysis & Winston Score
Galenica AG is a Swiss healthcare company that runs one of the largest pharmacy networks in Switzerland. It owns the Amavita, Sun Store, and Coop Vitality pharmacy chains, and it also distributes medicines and healthcare products to pharmacies, hospitals, and doctors across the country. The company sits at the center of Switzerland's pharmaceutical supply chain. Galenica makes most of its money by buying medicines and health products from manufacturers and selling them to end customers — either directly through its own pharmacies or by wholesaling to independent pharmacies through its Galexis distribution arm. It operates almost entirely within Switzerland, which gives it a stable, regulated market but also limits its growth potential. The main risk is that Swiss healthcare regulations and pricing controls can compress margins, and the company's low gross margin of around 10% leaves little room for error if costs rise or competition from online pharmacies increases.
Winston Score: 37/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (6/30)
- Growth: Mixed (5/20)
- Cash Flow: Strong (7/10)
- Stability: Strong (7/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)


